List of insiders holdings for Akero Therapeutics Inc.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
| ATP Life Science Ventures L.P. ATP III GP Ltd. 10% Owner | 2021-06-30 16:31:38 | 5,830,203 0 | 5,830,203 | Form 4 |
| Royston Aaron Director | 2019-06-25 18:05:51 | 0 3,954,858 | 3,954,858 | Form 4 |
| Bitterman Kevin Director | 2021-06-03 20:07:04 | 0 2,232,251 | 2,232,251 | Form 4 |
| Redmile Group LLC Green Jeremy 10% Owner | 2024-02-14 16:26:22 | 1,109,476 0 | 1,109,476 | Form 13G |
| Cheng Andrew President and CEO | 2024-11-05 09:00:35 | 904,561 0 | 904,561 | Form 4 |
| Versant Venture Capital VI L.P. Versant Ventures VI GP L.P. Versant Ventures VI GP-GP LLC 10% Owner | 2021-02-12 20:41:58 | 777,727 0 | 777,727 | Form 13G |
| venBio Global Strategic Fund II L.P. venBio Global Strategic GP II L.P. venBio Global Strategic GP II Ltd. Adelman Robert J GOODMAN COREY S 10% Owner | 2022-09-15 17:00:25 | 714,000 0 | 714,000 | Form 13D |
| Atlas Venture Fund XI L.P. Atlas Venture Associates XI LLC Atlas Venture Associates XI L.P. Atlas Venture Associates Opportunity I L.P. Atlas Venture Associates Opportunity I LLC Atlas Venture Opportunity Fund I L.P. 10% Owner | 2023-02-14 16:31:15 | 467,529 0 | 467,529 | Form 13G |
| Atlas Venture Fund XI L.P. 10% Owner | 2023-02-14 16:31:15 | 467,529 0 | 467,529 | Form 13G |
| Atlas Venture Opportunity Fund I L.P. 10% Owner | 2020-02-10 19:49:53 | 0 454,589 | 454,589 | Form 4 |
| Young Jonathan Chief Operating Officer | 2024-11-05 09:04:36 | 216,286 60,000 | 276,286 | Form 4 |
| Gangloff Scott A. Chief Technology Officer | 2024-05-01 19:36:34 | 225,000 0 | 225,000 | Form 4 |
| Rolph Timothy Chief Scientific Officer | 2024-09-13 17:11:41 | 180,705 0 | 180,705 | Form 4 |
| Yale Catriona Chief Development Officer | 2024-11-19 21:57:20 | 127,579 0 | 127,579 | Form 4 |
| White William Richard Chief Financial Officer | 2024-09-13 17:13:29 | 41,152 0 | 41,152 | Form 4 |
| Heyman Tomas J. Director | 2024-06-11 17:25:32 | 26,000 0 | 26,000 | Form 4 |
| Iwicki Mark T Director | 2024-06-11 17:28:06 | 26,000 0 | 26,000 | Form 4 |
| Graham G. Walmsley Director | 2024-06-11 17:29:55 | 26,000 0 | 26,000 | Form 4 |
| Xu Yuan Director | 2024-06-11 17:31:05 | 26,000 0 | 26,000 | Form 4 |
| Henderson Jane Director | 2024-06-11 17:24:20 | 26,000 0 | 26,000 | Form 4 |
| Harrison Seth Loring Director | 2024-06-11 17:22:56 | 26,000 0 | 26,000 | Form 4 |
| Judy Chou Director | 2024-06-11 17:20:52 | 26,000 0 | 26,000 | Form 4 |
| Lamy Patrick Senior VP, Commercial Strategy | 2024-07-02 18:56:16 | 18,783 0 | 18,783 | Form 4 |
| Skorpios Trust Blue Horizon Enterprise Ltd Ezbon International Ltd Montrago Trustees Ltd Former 10% owner | 2023-09-12 16:30:42 | 0 0 | 0 | Form 13G |